CARDIAC ARRHYTHMIAS IN METABOLIC SYNDROME
Abstract
The current concepts are given on metabolic syndrome, criteria of its diagnosis, peculiarities of medical treatment of different components of the metabolic syndrome, as well as the data on its influence on the incidence of cardiac arrhythmias and risk of sudden arrhythmic death.
About the Authors
V. D. Shurygina
СПбГМА им. И.И.Мечникова, Северо-Западный центр диагностики и лечения аритмий, Санкт-Петербург
Russian Federation
Russian Federation
Yu. V. Shubik
СПбГМА им. И.И.Мечникова, Северо-Западный центр диагностики и лечения аритмий, Санкт-Петербург
Russian Federation
Russian Federation
References
1. Gersh B.J., Tsang T.S.M., Seward J.B. The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. Transaction of the American clinical and climatological association 2004;115:P.149-160.
2. Ash-Bernal R., Peterson L.R. The cardiometabolic syndrome and cardiovascular disease. J Cardiometab Syndr 2006;1:25-28.
3. Umetani K., Kodama Y., Nakamura T. et al. High Prevalence of Paroxysmal Atrial Fibrillation and/or Atrial Flutter in Metabolic Syndrome. Circ J 2007;71:252-255.
4. H.Watanabe, N.Tanabe, T.Watanabe et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation. The Niigata Preventive Medicine Study. Circulation 2008; 117: I255-1260.
5. Nicolaou V.N., Papadakis J.E., Karatzis F.N. et al. Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation. Angiology 2007;58 (1):21-25.
6. Echahidi N., Mohty D., Pibarot P. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007; 116 (11): I213-1219.
7. Alpert M.A. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001;321 (4):225-236.
8. Bray G.A., Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006;29 (1):109-117.
9. Empana J.-P., Duciemetiere P., Balkau B., Jouven X. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I. EHJ 2007;28(9):1149-1154.
10. Soydinc S., Davutoglu V., Akcay M. Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol 2006;11(4):313-317.
11. Lown B., Verrier R.L. Neural activity and ventricular fibrillation. N Engl J Med 1976;294(21):1165-1170.
12. Verrier R.L., Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr Opin Cardiol 2004;19(1):2-11.
13. Park S.K., Schwartz J., Weisskopf M. et al. Low-Level Lead Exposure, Metabolic Syndrome, and Heart Rate Variability: The VA Normative Aging Study. Environ Health Perspect 2006;114(11):1718-1724.
14. Guidelines for the Management of Arterial Hypertension. EHJ 2007; 28: 1462-1536.
15. Miranda P.J., DeFronzo R.A., Califf R.M., Gryton J.R. Metabolic syndrome: definition, pathophysiology and mechanisms. Am Heart J 2005; 149: 33-45.
16. Ardern C.I., Janssen I., Ross R., Katzmarzyk P.T. Development of health-related waist circumference thresholds within BMI categories. Obes Res 2004;12:1094-1103.
17. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-553.
18. National Cholesterol Education Program, Adult Treatment Panel III, 2001. JAMA 2001; 285: 2486-2497.
19. Lakka H.M., Laaksonen D.E., Lakka T.A. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 27092716.
20. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;16;287(3):356-359.
21. Evans R.M., Barish G.D.,Wang Y.U. PPARs and the complex journey to obesity. Nat Med 2004; 10: 355-361.
22. Диагностика и лечение метаболического синдрома. Российские рекомендации. Приложение №2 к журналу «Кардиоваскулярная терапия и профилактика» 2007; 6: 1 - 26.
23. Kershaw E.E., Flier J.S. Adipose tissue as endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
24. Lindholm L.H., Persson M., Alaupovic P., e.a. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens 2003; 21: 1563-1574.
25. Amos A.F., McCarty D.J., Zimmet P. The rising global burdens of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 4(5): S7.
26. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, III пересмотр. Приложение №3 к журналу «Кардиоваскулярная терапия и профилактика» 2007; 6: 1 - 44.
27. Ryden L., Standi E., e.a. Diabetes, Pre-diabetes and Cardiovascular Diseases. EHJ, 2007; 28: 88-136.
28. J.T.Nguyen, D.G.Benditt. Atrial Fibrillation Susceptibility in Metabolic Syndrome. Simply the Sum of Its Parts? Circulation 2008; 117: I249-1251.
29. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. EHJ, 2006;27:1979-2030.
30. ACC/AHA/ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary. EHJ, 2006; 27: 2099-2140.
Review
For citations:
Shurygina V.D., Shubik Yu.V. CARDIAC ARRHYTHMIAS IN METABOLIC SYNDROME. Journal of Arrhythmology. 2008;53(53):56-63. (In Russ.)
Views:
253
Email this article 